Breast cancer; HER2-positive; metastatic

Clinical trials for Breast cancer; HER2-positive; metastatic explained in plain language.

Never miss a new study

Get alerted when new Breast cancer; HER2-positive; metastatic trials appear

Sign up with your email to follow new studies for Breast cancer; HER2-positive; metastatic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for advanced breast cancer: targeted drug combo tested in major trial

Disease control Ongoing

This study tests a new drug called trastuzumab deruxtecan (T-DXd), given alone or with another drug (pertuzumab), against the current standard treatment for HER2-positive breast cancer that has spread. About 1,157 people with this type of cancer will take part. The goal is to see…

Matched conditions: BREAST CANCER; HER2-POSITIVE; METASTATIC

Phase 3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

Breast cancer; HER2-positive; metastatic

Get alerted when new Breast cancer; HER2-positive; metastatic trials appear

New hope for advanced breast cancer: targeted drug combo tested in major trial